Tallaj JA, Franco V, Rayburn BK, Pamboukian SV, Benza RL, Kirklin JK, McGiffin DC, Smallfield M, Bourge RC
Safety and efficacy of ibutilide in heart transplant recipients. [Journal Article]
J Heart Lung Transplant 2009 May; 28(5):505-7.
In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.
More from this journal |
